ProShare Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-37,435
| Closed | -$384K | – | 1770 |
|
|
2016
Q3 | $384K | Sell |
37,435
-6,963
| -16% | -$71.4K | 0.01% | 1057 |
|
|
2016
Q2 | $580K | Buy |
44,398
+1,784
| +4% | +$23.3K | 0.01% | 906 |
|
|
2016
Q1 | $469K | Sell |
42,614
-4,314
| -9% | -$47.5K | 0.01% | 1027 |
|
|
2015
Q4 | $432K | Buy |
46,928
+3,869
| +9% | +$35.6K | 0.01% | 1110 |
|
|
2015
Q3 | $299K | Sell |
43,059
-2,831
| -6% | -$19.7K | ﹤0.01% | 1148 |
|
|
2015
Q2 | $451K | Sell |
45,890
-4,966
| -10% | -$48.8K | 0.01% | 1137 |
|
|
2015
Q1 | $451K | Buy |
50,856
+6,256
| +14% | +$55.5K | 0.01% | 1234 |
|
|
2014
Q4 | $391K | Sell |
44,600
-2,082
| -4% | -$18.3K | ﹤0.01% | 1344 |
|
|
2014
Q3 | $322K | Sell |
46,682
-9,557
| -17% | -$65.9K | ﹤0.01% | 1672 |
|
|
2014
Q2 | $296K | Sell |
56,239
-39,162
| -41% | -$206K | ﹤0.01% | 1922 |
|
|
2014
Q1 | $434K | Buy |
95,401
+68,020
| +248% | +$309K | 0.01% | 1981 |
|
|
2013
Q4 | $138K | Sell |
27,381
-25,908
| -49% | -$131K | ﹤0.01% | 1285 |
|
|
2013
Q3 | $270K | Buy |
53,289
+6,008
| +13% | +$30.4K | 0.01% | 1971 |
|
|
2013
Q2 | $235K | Buy |
+47,281
| New | +$235K | ﹤0.01% | 1910 |
|